Toolkit/Untargeted LC-MS metabolomics
Untargeted LC-MS metabolomics
Also known as: untargeted metabolomics analysis via liquid chromatography-mass spectrometry (LC-MS)
Taxonomy: Technique Branch / Method. Workflows sit above the mechanism and technique branches rather than replacing them.
Summary
an untargeted metabolomics analysis via liquid chromatography-mass spectrometry (LC-MS)
Usefulness & Problems
Why this is useful
This method measures metabolite differences in rabbit plaque tissue using untargeted LC-MS. In the study it was used to identify altered metabolites in plaques under positive and negative ion modes.; profiling metabolite fingerprints in rabbit arterial plaques
Source:
This method measures metabolite differences in rabbit plaque tissue using untargeted LC-MS. In the study it was used to identify altered metabolites in plaques under positive and negative ion modes.
Source:
profiling metabolite fingerprints in rabbit arterial plaques
Problem solved
It helps uncover metabolite fingerprints and pathway-linked metabolic changes in atherosclerotic plaques.; detects metabolite changes associated with atherosclerotic plaque tissue
Source:
It helps uncover metabolite fingerprints and pathway-linked metabolic changes in atherosclerotic plaques.
Source:
detects metabolite changes associated with atherosclerotic plaque tissue
Problem links
detects metabolite changes associated with atherosclerotic plaque tissue
LiteratureIt helps uncover metabolite fingerprints and pathway-linked metabolic changes in atherosclerotic plaques.
Source:
It helps uncover metabolite fingerprints and pathway-linked metabolic changes in atherosclerotic plaques.
Published Workflows
Objective: Explore potential mechanisms and molecular signatures associated with rabbit atherosclerotic plaques by integrating proteomics and untargeted metabolomics analyses of abdominal aortas.
Why it works: The workflow combines protein and metabolite profiling from plaque tissue, then links these layers using statistical correlation and pathway enrichment to reveal coordinated molecular signatures.
Stages
- 1.Rabbit model and tissue collection(library_build)
This stage generates the plaque and control tissue inputs required for comparative multi-omics profiling.
Selection: Experimental rabbits were divided into model and sham groups, and abdominal aortas were isolated and collected for downstream analysis.
- 2.Quantitative proteomics profiling(functional_characterization)
This stage identifies proteins altered between injured and uninjured aortas.
Selection: TMT-labeled quantitative proteomics was performed on abdominal aorta samples to evaluate protein fingerprints in arterial plaques.
- 3.Untargeted metabolomics profiling(functional_characterization)
This stage identifies metabolites altered in plaque tissue, including lipid components and pathway-linked metabolites.
Selection: Untargeted LC-MS metabolomics was performed on abdominal aorta samples to evaluate metabolite fingerprints in arterial plaques.
- 4.Integrated statistical and pathway analysis(secondary_characterization)
This stage integrates protein and metabolite changes to infer correlated molecular signatures and implicated pathways.
Selection: Acquired data were analyzed using uni- and multivariate statistics, Pearson correlation, and KEGG enrichment analysis.
Steps
- 1.Assign rabbits to model and sham groups
Create plaque and control cohorts for comparative analysis.
Group assignment is required before tissue collection and downstream omics measurements.
- 2.Isolate and collect abdominal aortas
Obtain tissue samples for proteomic and metabolomic profiling.
Tissue collection must precede sample preparation and omics analysis.
- 3.Treat collected aortas with proteinase K
Prepare collected aortic tissue for downstream analysis.
The abstract places proteinase K treatment after tissue collection and before omics assays.
- 4.Perform TMT-labeled quantitative proteomics analysisassay method
Measure protein fingerprints in arterial plaques.
Proteomic measurement follows tissue collection and preparation to generate one molecular layer for integrated analysis.
- 5.Perform untargeted LC-MS metabolomics analysisassay method
Measure metabolite fingerprints in arterial plaques.
Metabolomic measurement provides the second molecular layer needed for integrated analysis after tissue collection and preparation.
- 6.Analyze acquired data using uni- and multivariate statistics
Identify differential molecular features from the acquired omics data.
Statistical analysis follows data acquisition to determine which proteins and metabolites differ between groups.
- 7.Compute Pearson correlations between differentially abundant proteins and metabolites
Link altered proteins and metabolites across omics layers.
Correlation analysis requires differential protein and metabolite features identified from prior assays and statistics.
- 8.Predict involved functional pathways using KEGG enrichment analysis
Interpret altered molecular features in terms of biological pathways.
Pathway prediction is performed after differential features and correlations are available for biological interpretation.
Taxonomy & Function
Primary hierarchy
Technique Branch
Method: A concrete measurement method used to characterize an engineered system.
Mechanisms
differential abundance analysisliquid chromatographic separationmass spectrometric detection of metabolitesuntargeted metabolite profilingTechniques
Functional AssayTarget processes
recombinationImplementation Constraints
The abstract supports the need for collected abdominal aorta tissue and LC-MS-based untargeted metabolomics analysis.; requires abdominal aorta tissue samples and LC-MS metabolomics analysis
The abstract does not show that untargeted metabolomics alone proves mechanism or confirms diagnostic performance of specific metabolites.; the abstract does not provide full structural resolution or downstream validation of reported metabolites
Validation
Supporting Sources
Ranked Claims
Injured rabbit aortas with plaques show 207 significantly altered proteins compared with uninjured aortas, including 133 upregulated and 74 downregulated proteins.
A total of 207 proteins are significantly altered in injured aortas compared to uninjured ones, with 133 upregulated and 74 downregulated proteins (fold changes > 1.2, P < 0.05).
Rabbit plaques show 234 significantly changed metabolites in positive ion mode and 187 in negative ion mode.
In plaques, 234 metabolites are significantly changed under the positive ion mode, and 187 under the negative ion mode.
Phosphatidylcholines and lysophosphatidylcholines, including PC 9:0 and LPC 20:2, are increased in rabbit plaques.
Notably, increases are observed in phosphatidylcholines (PCs) [PC 9:0] and lysophosphatidylcholines (LPCs) [LPC 20:2], two key lipid components.
Altered plaque metabolites are involved in purine metabolism and vascular smooth muscle contraction pathways.
These metabolites are involved in some key metabolic pathways, including purine metabolism and vascular smooth muscle contraction.
Approval Evidence
an untargeted metabolomics analysis via liquid chromatography-mass spectrometry (LC-MS)
Source:
Rabbit plaques show 234 significantly changed metabolites in positive ion mode and 187 in negative ion mode.
In plaques, 234 metabolites are significantly changed under the positive ion mode, and 187 under the negative ion mode.
Source:
Phosphatidylcholines and lysophosphatidylcholines, including PC 9:0 and LPC 20:2, are increased in rabbit plaques.
Notably, increases are observed in phosphatidylcholines (PCs) [PC 9:0] and lysophosphatidylcholines (LPCs) [LPC 20:2], two key lipid components.
Source:
Altered plaque metabolites are involved in purine metabolism and vascular smooth muscle contraction pathways.
These metabolites are involved in some key metabolic pathways, including purine metabolism and vascular smooth muscle contraction.
Source:
Comparisons
Source-stated alternatives
The paper explicitly combines this method with TMT quantitative proteomics to obtain integrated molecular signatures.
Source:
The paper explicitly combines this method with TMT quantitative proteomics to obtain integrated molecular signatures.
Source-backed strengths
captures broad metabolite changes in both positive and negative ion modes
Source:
captures broad metabolite changes in both positive and negative ion modes
Compared with barcoded Cre recombinase mRNA barcode platform
Untargeted LC-MS metabolomics and barcoded Cre recombinase mRNA barcode platform address a similar problem space because they share recombination.
Shared frame: same top-level item type; shared target processes: recombination
Compared with calcium imaging
Untargeted LC-MS metabolomics and calcium imaging address a similar problem space because they share recombination.
Shared frame: same top-level item type; shared target processes: recombination
Relative tradeoffs: appears more independently replicated.
Compared with two-photon excitation microscopy
Untargeted LC-MS metabolomics and two-photon excitation microscopy address a similar problem space because they share recombination.
Shared frame: same top-level item type; shared target processes: recombination
Strengths here: looks easier to implement in practice.
Ranked Citations
- 1.